Cargando…
BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions
Multiple sclerosis (MS) has traditionally been viewed as a chronic inflammatory disease affecting the white matter of the central nervous system. However, over the past two decades, increasing evidence has highlighted the role of gray matter pathology in MS-related disability. Numerous studies have...
Autores principales: | Gupta, Kanak, Kesharwani, Ajay, Rua, Steven, Singh, Saumitra Sen, Siu, Catherine, Jank, Larissa, Smith, Matthew D., Calabresi, Peter A., Bhargava, Pavan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559498/ https://www.ncbi.nlm.nih.gov/pubmed/37805549 http://dx.doi.org/10.1186/s12974-023-02922-7 |
Ejemplares similares
-
BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
por: Zhou, Xiaohui, et al.
Publicado: (2011) -
April and Baff Connect Autoimmunity and Cancer
por: Ware, Carl F.
Publicado: (2000) -
Microglia and meningeal macrophages depletion delays the onset of experimental autoimmune encephalomyelitis
por: Montilla, Alejandro, et al.
Publicado: (2023) -
Siponimod Inhibits the Formation of Meningeal Ectopic Lymphoid Tissue in Experimental Autoimmune Encephalomyelitis
por: Brand, Rosa Margareta, et al.
Publicado: (2021) -
The current status of targeting BAFF/BLyS for autoimmune diseases
por: Ramanujam, Meera, et al.
Publicado: (2004)